The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.
The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.
The Department of Health and Human Services (HHS) issued a statement on Sunday:
The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.
North Carolina’s longest-serving governor dies at 88 after serving 4 terms in office
Milwaukee County judge found guilty of obstructing federal immigration agents in courthouse incident
BREAKING: Deceased Brown Shooting Suspect ID’d as 48-Year-Old Portuguese National, Student at Brown
US military strikes narco-terrorist vessels in latest Eastern Pacific drug trafficking operation
Maria Shriver slams Trump over Kennedy Center name change decision: ‘Beyond comprehension’
Minneapolis police chief blasts ICE after agent seen dragging woman through street, kneeling on her back
Claudio Manuel Neves-Valente identified as Brown University shooting suspect, found dead
Trump quietly signs sweeping $901B defense bill after bipartisan Senate passage
Justice Department prepares to drop trove of Epstein files as deadline looms
Erika Kirk vows to get Vance ‘elected for 48’ at AmericaFest
Top Mamdani appointee dramatically quits after antisemitic posts resurface
Kennedy Center for Performing Arts Getting Name Change Under Trump’s Leadership
Florida executes man convicted of killing airman and girlfriend in 1987 home invasion
A Year Before His Tragic Death, NASCAR’s Greg Biffle Saved Lives in Flood-Ravaged North Carolina
Transportation Secretary’s Daughter Calls for Complete Eradication of TSA After Nightmare Airport Experience
HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”
Earlier, the French government had approved similar drugs to treat the virus.
Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”
North Carolina’s longest-serving governor dies at 88 after serving 4 terms in office
Milwaukee County judge found guilty of obstructing federal immigration agents in courthouse incident
BREAKING: Deceased Brown Shooting Suspect ID’d as 48-Year-Old Portuguese National, Student at Brown
US military strikes narco-terrorist vessels in latest Eastern Pacific drug trafficking operation
Maria Shriver slams Trump over Kennedy Center name change decision: ‘Beyond comprehension’
Minneapolis police chief blasts ICE after agent seen dragging woman through street, kneeling on her back
Claudio Manuel Neves-Valente identified as Brown University shooting suspect, found dead
Trump quietly signs sweeping $901B defense bill after bipartisan Senate passage
Justice Department prepares to drop trove of Epstein files as deadline looms
Erika Kirk vows to get Vance ‘elected for 48’ at AmericaFest
Top Mamdani appointee dramatically quits after antisemitic posts resurface
Kennedy Center for Performing Arts Getting Name Change Under Trump’s Leadership
Florida executes man convicted of killing airman and girlfriend in 1987 home invasion
A Year Before His Tragic Death, NASCAR’s Greg Biffle Saved Lives in Flood-Ravaged North Carolina
Transportation Secretary’s Daughter Calls for Complete Eradication of TSA After Nightmare Airport Experience
President Donald Trump has suggested that hydroxychloroquine could be effective, and has encouraged further study. His interest in the drug has prompted pushback from the media.
NBC News’ Peter Alexander accused the president last week of giving Americans “false hope,” and Politico’s Dan Diamond reported Sunday that the FDA decision came despite “scant evidence,” adding that “[c]areer scientists have been skeptical of the effort.”
Story cited here.
